Biomedical Laboratory Science

ShareThis

Saturday, December 2, 2017

Human Microbiome and its Association With Health and Diseases

Human microbiota are distinct communities of microorganisms that resides at different body niches. Exploration of the human microbiome has become a reality due to the availability of powerful metagenomics and metatranscriptomic analysis technologies. Recent advances in sequencing and bioinformatics over the past decade help provide a deep insight into the nature of the host-microbial interactions and identification of potential deriver genes and pathways associated with human health, well-being, and predisposition to different diseases. In the present review, we outline recent studies devoted to elucidate the possible link between the microbiota and various type of diseases. The present review also highlights the potential utilization of microbiota as a potential therapeutic option to treat a wide array of human diseases.

Humans are viewed as composites of human and microbial cells. Human microbiota are complex and dynamic microbial communities composed mainly of bacteria, but also includes protozoa, archaea, viruses, and fungi that resides in and on different body niches such as oral cavity, throat, esophagus, stomach, colon, urogenital tract, respiratory tract, and skin. The number of microbial cells inhabiting human body is estimated to exceed the H.sapiens cells by 10-fold and estimated at 350 trillion microbial cells.


Microbiome-host interactions. Schematic representation showing the perplexed microbial-host
interactions due to different triggering factors on microbiota and their genetic material constitute;
the human microbiome.
Source: Wiley

Friday, December 1, 2017

Herpes gladiatorum: Facts, Symptoms, Causes, Risk Factors, Diagnosis, Treatments, Prevention and Outlook.


Herpes gladiatorum is an infection caused by herpes simplex virus type 1, a virus similar to that which causes cold sores. It is common among those who engage in high-contact sports, such as wrestling, and is also known as mat herpes. Those infected with herpes will carry the virus with them for life as there is no cure.




There will be periods where the virus is inactive and no symptoms are present, and times where it is active and causes various symptoms and flare-ups.

When the virus is active, the person carrying it is infectious and can spread herpes gladiatorum to others. The virus can be transmitted by skin-to-skin contact and is easily passed from one person to the next.

In this article, we examine the symptoms of herpes gladiatorum and the parts of the body that can be affected. We also take a look at diagnosis, treatment, and prevention of the condition.




Thursday, November 30, 2017

How to Apply Today for Sanima Equity Fund Using Online ASBA Service (Step-by-Step Process of Global IME Bank Online ASBA)

SEBON had compulsorily implemented Applications Supported by Blocked Amount (ASBA) system from Shrawan 1, 2074 for public issues (IPO/FPO/MF) and Sanima Capital Ltd. is the next company issuing its Sanima Equity Fund from full ASBA services all over Nepal starting from Tuesday November 28th 2017. Global IME Bank (GBIME), like several other banks, has come up with online ASBA service registration of application for share with the aim to provide easy and efficient services to its customers.



ShareUpdateNepal


The customers can use ASBA services from either mobile banking or internet banking service without being presented at the bank and also at zero cost for the applications of IPO, FPO and Mutual Funds, such as, this Sanima Equity Fund.




Applicants having account in Global IME Bank can apply Sanima Equity Fund through online service for registration of application.


Here is a step-by-step process to apply for the Sanima Equity Fund using the online ASBA system:

STEP 1: Open Global IME Internet Banking by clicking on the link below.





STEP 2: Position the cursor at ASBA ONLINE at top right corner as shown.




STEP 3: Click login after entering your online banking username and password as shown.




STEP 4: You will have 'Share Application Form' to enter your information details as shown as shown.


List of available public offerings along with details on the apply button of
the 
public offering for application submission.

STEP 5: Complete the upper portion of the form with your information into the fields as shown.

Note at the bottom the 'available balance' of your account !


STEP 6:
 Scroll down and complete the bottom portion of the form with your information into the fields as shown.


Read the terms and conditions in the box at the bottom,check the circle to mark
your agreement and thenclick 'Apply' in the red box at the bottom.


STEP 7: Click 'Confirm' (or 'Edit' if incorrect) for share conformation as shown.




STEP 8: You will get a dialog box from the Global IME Bank on your screen displaying that 'A code has been sent to your registered mobile number' in green box with details as shown.




STEP 9: Enter into the 'OTP' box the 6 digit code sent to your registered mobile number and hit 'Submit' in the red box at the bottom as shown.




STEP 10: If everything goes well, you will get a 'Customer Verification' dialog box displaying 'Your account details has been verified successfully.', then hit the 'Submit Form' in the red box at the bottom as shown.




STEP 11: You will then be offered 'ASBA Receipt' dialog box with the 'PDF' icon link, click it to download your receipt as shown.




STEP 12: Finally, save the pdf ASBA receipt for your future reference as shown.




That is it! You are done!! Hope this helps & Good Luck!!!


ShareUpdateNepal: Thursday November 30th 2017


ALSO,  CHECK THESE OUT TOO!

Sanima Capital Issues Sanima Equity Fund from Nov 28 to Dec 1, 2017 !

Support Microfinance IPO Starting from Tomorrow, How is the Company?




Wednesday, November 29, 2017

Sanima Capital Issues Sanima Equity Fund from Nov 28 to Dec 1, 2017 !

Sanima Equity Fund is being floated its public issue of 120 million (12 crore) unit shares worth Rs. 1.20 billion (arba) for 4 days starting from November 28th 2017 (Mangsir 12th, 2074) till December 1st 2017 (Mangsir 15th, 2074).




The Equity Fund is a closed-end 7-years equity oriented mutual fund scheme with fund size of Rs. 1.20 billion (arba). The mutual fund is managed by Sanima Capital Limited, a subsidiary company of Sanima Bank Limited (SANIMA), its fund sponsor.




Out of the total units, 15 percent, i.e., 18 million mutual fund units have been allocated to the promoter of the mutual fund, Sanima Bank and the remaining units will be issued to the general public.




Check the link below to see or download the NOTICE:



The offer will close on December 1st 2017 (Mangsir 15th, 2074) at the earliest, else the maximum closing date for the offer is December 12th 2017 (Mangsir 26th, 2074).




Interested people must apply for a minimum of 100 units of share and can apply maximum for up to 2.4 million unit of shares.




Check the link below to see or download the AAHWAANPATRA RELEASE:


The mutual fund will be issuing a total of 12 crore unit of ordinary shares worth Rs. 1.20 billion (arba) at face value of Rs. 10 per unit.


Check the link below to see or download the PROSPECTUS:


Check the link below to see or download the PRESS RELEASE:



Interested applicants can apply through ASBA-approved banks from all 75 districts across the country.

Check the link below to apply using online step-by-step ASBA SERVICE:


Saturday, November 18, 2017

Roitt's Essential Immunology, 13th Edition !

Roitt's Essential Immunology, 13th Edition pdf










Roitt's Essential Immunology - the textbook of choice for students and instructors of immunology worldwide
Roitt’s Essential Immunology clearly explains the key principles needed by medical and health sciences students, from the basis of immunity to clinical applications.  A brand new introduction sets the scene to section 1, Fundamentals of Immunology, introducing the microbial world and the strategies the body employs to defend itself. Each chapter then guides the reader through a different part of the immune system, and explains the role of each cell or molecule individually, and then as a whole.  Section 2, Applied Immunology, discusses what happens when things go wrong, and the role the immune system plays alongside the damaging effects of a disease, including cancer, immunodeficiency, allergies and transplantation and the beneficial effects of vaccines......


Estradiol Patches Now Fully Subsidized: What Is Their Place In The Treatment Of Menopausal Symptoms?

Transdermal estradiol patches (25, 50 and 100 microgram Estradot brand patches) are now fully subsidised, without the need for Special Authority approval, as a form of menopausal hormone therapy (MHT) for the treatment of menopausal symptoms. From 1 January, 2017, a 75 microgram patch will also be available.

Previously, Climara brand 50 and 100 microgram patches were available through Special Authority funding. The Special Authority funding for these medicines was removed on 1 October, 2016, and Climara brand 50 and 100 microgram patches will be delisted from 1 January, 2017. Patients who are currently using Climara patches and require ongoing treatment will need to switch to Estradot brand patches.







Source: bpac

Sunday, November 12, 2017

Siddhartha Equity Fund Allotment Concludes, Check Your Result Now!

Siddhartha Equity Fund has concluded its public issue allotment today at Siddhartha Capital Limited, Naxal, Kathmandu.

Applicants who had applied up to 8 lakh units (up to Rs 80 lakh) were allotted as much as they had applied for. Among 41 applicants who had applied 10 lakh units to 24 lakh units (Rs 1 crore to Rs 2.40 crore), 33 applicants were allotted 967,748 units each and 8 applicants were allotted 967,747 units each. The remaining 2.25 crore units were allotted to Siddhartha Bank as the fund sponsor.




Out of 29,573 applicants, 29,549 applicants were allotted. There were 24 invalid applicants.

Although Siddhartha Equity Fund had floated its public issue of 12 crore unit shares worth Rs 1.20 arba, the fund size was increased by 25% to Rs 1.50 arba due to oversubscription. SEF had floated public issue from Ashwin 25, 2074 to Ashwin 30, 2074. 15% units was reserved for Siddhartha Bank.




Siddhartha Equity Fund is a closed-end 10-years equity oriented mutual fund scheme with fund size of Rs 1.50 arba. The mutual fund is managed by Siddhartha Capital Limited and Siddhartha Bank Limited is its fund sponsor.



Siddhartha Capital already has its two mutual fund schemes named Siddhartha Investment Growth Scheme (SIGS1) and Siddhartha Equity Oriented Scheme (SEOS), and both are listed in NEPSE.




Siddhartha Equity Oriented Limited (SEOS) and Siddhartha Investment Growth Scheme-1 (SIGS1)—closed-end 5 years mutual fund schemes, SIGS1 and SEOS have reported net asset value (NAV) of Rs 21.55 and Rs 13.21 respectively in Ashwin 2074 end.

Check the link below to see the result at Sharesansar Site:




Check the link below to see the result at Bizpati Site:



Check the link below to see the result at Siddhartha Capital Site:





Check the link below to see all allottees list in excel format:



ShareUpdateNepal: Sunday 12th November 2017
Related Posts Plugin for WordPress, Blogger...

AddToAny